These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 3475393)

  • 1. The detection of colorectal carcinomas with the use of CA-50 radioimmunoassay inhibition test.
    Habib NA; Hershman MJ; Papp L; Swift I; Williamson RC; Wood CB
    Int J Colorectal Dis; 1986 Jul; 1(3):186-7. PubMed ID: 3475393
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CA-50 as a tumour marker for monitoring colorectal cancer: antigen rises in patients postoperatively precede clinical manifestations of recurrence.
    Persson BE; Ståhle E; Påhlman L; Glimelius B; Holmgren J
    Eur J Cancer Clin Oncol; 1988 Feb; 24(2):241-6. PubMed ID: 2451612
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A clinical study of CA-50 as a tumour marker for monitoring of colorectal cancer.
    Persson BE; Ståhle E; Påhlman L; Glimelius B; Nilsson O; Lindholm L; Norrgård-Pedersen B; Holmgren J
    Med Oncol Tumor Pharmacother; 1988; 5(3):165-71. PubMed ID: 3166084
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of CA 19-9 and carcinoembryonic antigen (CEA) levels in the serum of patients with colorectal diseases.
    Kuusela P; Jalanko H; Roberts P; Sipponen P; Mecklin JP; Pitkänen R; Mäkelä O
    Br J Cancer; 1984 Feb; 49(2):135-9. PubMed ID: 6582896
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sensitivity of monoclonal antibodies to carcinoembryonic antigen, tissue polypeptide antigen, alpha-fetoprotein, carbohydrate antigen 50, and carbohydrate antigen 19-9 in the diagnosis of colorectal adenocarcinoma.
    Alvarez JA; Marín J; Jover JM; Fernández R; Fradejas J; Moreno M
    Dis Colon Rectum; 1995 May; 38(5):535-42. PubMed ID: 7537651
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improved detection of the early stages of colon cancer by determining both free circulating and immune complex-bound antigens reactive with monoclonal antibody.
    Chester SJ; Lim YP; Vezeridis MP; Hixson DC
    Cancer Res; 1994 Aug; 54(15):3974-8. PubMed ID: 8033125
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [CA-50 in serum of patients with carcinoma. Clinical experiences with a new tumor marker].
    Bruhn HD; Broers H; Euler H; Everding A; Feller AC; Hedderich J; Jostarndt L; Jooss B; Zurborn KH; Löffler H
    Dtsch Med Wochenschr; 1986 Aug; 111(34):1267-72. PubMed ID: 3461933
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The preoperative carcinoembryonic antigen test in the diagnosis, staging, and prognosis of colorectal cancer.
    Moertel CG; O'Fallon JR; Go VL; O'Connell MJ; Thynne GS
    Cancer; 1986 Aug; 58(3):603-10. PubMed ID: 3731019
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A clinical evaluation of carbohydrate antigen 19-9 and carcinoembryonic antigen in patients with pancreatic carcinoma.
    Satake K; Kanazawa G; Kho I; Chung YS; Umeyama K
    J Surg Oncol; 1985 May; 29(1):15-21. PubMed ID: 3857396
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation of the Serum Level of Carcinoembryonic Antigen and Prolactin with Different Stages of Colorectal Carcinoma According to Dukes' Staging.
    Rahman MR; Sheikh SH; Lima IJ; Islam MR; Faisal M; Islam MS; Faruk MO; Jalal MT
    Mymensingh Med J; 2016 Jan; 25(1):61-5. PubMed ID: 26931251
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pre-operative serum levels of CA 242 and CEA predict outcome in colorectal cancer.
    Carpelan-Holmström M; Haglund C; Lundin J; Järvinen H; Roberts P
    Eur J Cancer; 1996 Jun; 32A(7):1156-61. PubMed ID: 8758246
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Comparison of the tumor markers CEA and CA 19-9 in colorectal diagnosis].
    Heptner G; Domschke S; Krapf F; Schneider MU; Iro H; Domschke W
    Dtsch Med Wochenschr; 1984 Aug; 109(35):1309-12. PubMed ID: 6590287
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The clinical validity of circulating tumor-associated antigens CEA and CA 19-9 in primary diagnosis and follow-up of patients with gastrointestinal malignancies.
    Staab HJ; Brümmendorf T; Hornung A; Anderer FA; Kieninger G
    Klin Wochenschr; 1985 Feb; 63(3):106-15. PubMed ID: 3856076
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Diagnosis and treatment of colorectal cancer using monoclonal antibodies].
    Inagi H; Okuda H; Shimano T; Kadota T; Mori T
    Gan To Kagaku Ryoho; 1986 Jul; 13(7):2291-7. PubMed ID: 3460528
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Significance of measurement of a carbohydrate antigenic determinant 19-9 (CA 19-9) for monitoring colorectal cancer patients.
    Tomoda H; Furusawa M
    Jpn J Surg; 1986 Jan; 16(1):73-5. PubMed ID: 2421035
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monoclonal antibody immunoradiometric assay for an antigenic determinant (CA 72) on a novel pancarcinoma antigen (TAG-72).
    Klug TL; Sattler MA; Colcher D; Schlom J
    Int J Cancer; 1986 Nov; 38(5):661-9. PubMed ID: 2429934
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of four serum tumour markers in the diagnosis of colorectal carcinoma.
    van der Schouw YT; Verbeek AL; Wobbes T; Segers MF; Thomas CM
    Br J Cancer; 1992 Jul; 66(1):148-54. PubMed ID: 1379057
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Value of serum levels of carcinoembryonic antigen, CEA, and gastrointestinal cancer antigen, GICA or CA 19-9, for preoperative staging and postoperative monitoring of patients with colorectal carcinoma.
    Szymendera JJ; Nowacki MP; Kozłowicz-Gudzińska I; Kowalska M
    Dis Colon Rectum; 1985 Dec; 28(12):895-9. PubMed ID: 3864628
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An analysis of immunocomplexes for the detection of the early stages of colon cancer.
    Chester SJ; Maimonis P; Meitner PA; Vezeridis MP
    Cancer; 1990 Mar; 65(6):1338-44. PubMed ID: 2306682
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Ca 12-5 in stomach and colorectal cancer. A comparison with the tumor markers CEA and Ca 19-9].
    Quentmeier A; Schlag P; Geisen HP; Schmidt-Gayk H
    Med Klin (Munich); 1986 Mar; 81(6):199-201. PubMed ID: 3466003
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.